Efficacy of nelfinavir as monotherapy in refractory adenoid cystic carcinoma: Results of a phase II clinical trial - Test2 - elhamkhani - TriplyDB

Efficacy of nelfinavir as monotherapy in refractory adenoid cystic carcinoma: Results of a phase II clinical trial

Efficacy of nelfinavir as monotherapy in refractory adenoid cystic carcinoma: Results of a phase II clinical trial

http://www.wikidata.org/entity/Q34848294

about

Redox Homeostasis and Cellular Antioxidant Systems: Crucial Players in Cancer Growth and Therapy Adenoid cystic carcinoma: current therapy and potential therapeutic advances based on genomic profiling Nelfinavir and other protease inhibitors in cancer: mechanisms involved in anticancer activity Adenoid cystic carcinoma: A review of recent advances, molecular targets, and clinical trials.Marketed nonsteroidal anti-inflammatory agents, antihypertensives, and human immunodeficiency virus protease inhibitors: as-yet-unused weapons of the oncologists' arsenal.HIV-protease inhibitors for the treatment of cancer: Repositioning HIV protease inhibitors while developing more potent NO-hybridized derivatives?

P2860

Q26740191-E962C800-843D-4C04-8AAF-6F5DB3D8FDCE Q26781643-D35A1C8E-347D-4F74-88D5-2F8B6A112258 Q28083142-CFF2D4AC-6650-47DF-B839-9BF29ED36620 Q30301145-409F3019-F211-4A8F-AE0F-B8D1CE212933 Q35653603-E77B4CC9-4F3C-454A-BC87-77F9D364892E Q39015233-028A7652-E18C-4F88-A713-7BABAFF58320

P2860

Efficacy of nelfinavir as monotherapy in refractory adenoid cystic carcinoma: Results of a phase II clinical trial

http://www.wikidata.org/entity/Q34848294

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Efficacy of nelfinavir as mono ...... s of a phase II clinical trial

@ast

Efficacy of nelfinavir as mono ...... s of a phase II clinical trial

@en

Efficacy of nelfinavir as mono ...... s of a phase II clinical trial

@nl

type

label

Efficacy of nelfinavir as mono ...... s of a phase II clinical trial

@ast

Efficacy of nelfinavir as mono ...... s of a phase II clinical trial

@en

Efficacy of nelfinavir as mono ...... s of a phase II clinical trial

@nl

prefLabel

Efficacy of nelfinavir as mono ...... s of a phase II clinical trial

@ast

Efficacy of nelfinavir as mono ...... s of a phase II clinical trial

@en

Efficacy of nelfinavir as mono ...... s of a phase II clinical trial

@nl

P1433

Q34848294-C9450B34-E158-4613-A8B5-4D73EE7E1604

P1476

Q34848294-6E28548B-D15D-4150-BEE3-0D8DB7C6197A

P2093

Q34848294-475399E4-648E-40B1-9B7C-40018C9CF166

Q34848294-D2EB0D0B-75DC-49A0-99C9-8B1FB6D2A000

P2860

Q34848294-00E35E8B-B4EF-4311-BE6C-8D5135F44E59

Q34848294-05373191-8279-4538-97B5-ADD83CA0D0CB

Q34848294-05F73B67-04C3-47FB-9937-D09DAD28F03E

Q34848294-105806B7-9B01-4FDA-BC80-8E9885609807

Q34848294-1F2474EA-A306-42E8-8290-D01DF72F8BC2

Q34848294-20FADA81-A805-401D-9617-F3AD42C504D0

Q34848294-2840BC35-F057-4F06-BE70-CE7A8E0F993F

Q34848294-2BEA8500-E857-4393-816F-4EAD9761ED42

Q34848294-38B1AE73-3A0B-40AE-9D0D-513B1552AB4E

Q34848294-473DBE29-F40D-4BF8-B817-CDC4CEDB2FF7

P304

Q34848294-4EC2F745-BCCB-4DB7-B556-523D338DF06E

P31

Q34848294-B4C5A964-1CFC-49CC-A2D4-6366DFD3C5EB

P356

Q34848294-FE073B58-5220-4FD5-A18E-33713554E995

P433

Q34848294-D0F305CD-CCEA-4163-9B6C-47BEE32CAA15

P478

Q34848294-788DD0DE-0D3E-476C-8C5C-BD1A86E884AF

P50

Q34848294-2C066CCF-C062-4A29-A427-5CDEF2312595

Q34848294-4289169A-2CB9-446F-9BF6-28204DA1E62F

Q34848294-50F295EA-F703-44EB-B7D9-7D91718507DE

Q34848294-F0CF3CB2-05E0-4F48-806B-160664AD8A63

Q34848294-FFD8FA38-62C4-4280-8C57-591A3AE2A2A4

P577

Q34848294-BCB83E29-8D62-441A-9B97-485E1029E798

P5875

Q34848294-24ACB1C2-982E-40D8-9213-50BBCAC5F18C

P698

Q34848294-7A09D9DC-0B42-4259-A0CF-C6693814A2DF

P921

Q34848294-3FE89D40-F154-4B88-81CF-BFC0E4400A4C

Q34848294-61B6D93A-138F-409D-9225-30AF354706E8

P932

Q34848294-1246AF70-A824-46F9-AD33-5779A3CBEEB5

P356

P1433

P1476

Efficacy of nelfinavir as mono ...... s of a phase II clinical trial

@en

P2093

Andrew C Hoover

http://www.w3.org/2001/XMLSchema#string

Brian J Smith

http://www.w3.org/2001/XMLSchema#string

P2860

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

Tamoxifen enhances the cytotoxic effects of nelfinavir in breast cancer cells.

Two hits are better than one: targeting both phosphatidylinositol 3-kinase and mammalian target of rapamycin as a therapeutic strategy for acute leukemia treatment.

Adenoid cystic carcinoma: a retrospective clinical review.

Adenoid cystic carcinoma of the head and neck.

PIK3CA mutations in patients with advanced cancers treated with PI3K/AKT/mTOR axis inhibitors.

A phase I trial of the HIV protease inhibitor nelfinavir with concurrent chemoradiotherapy for unresectable stage IIIA/IIIB non-small cell lung cancer: a report of toxicities and clinical response.

Salivary gland adenoid cystic carcinoma: a review of chemotherapy and molecular therapies.

The impact of nelfinavir exposure on cancer development among a large cohort of HIV-infected patients

Targeting phosphatidylinositol 3 kinase (PI3K)-Akt beyond rapalogs.

P304

722-726

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/HED.23664

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

37

http://www.w3.org/2001/XMLSchema#string

P50

Henry T Hoffman

Carryn M Anderson

P577

2014-06-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260557756

http://www.w3.org/2001/XMLSchema#string

P698

24596143

http://www.w3.org/2001/XMLSchema#string

P921

phase II clinical trial

P932

4285572

http://www.w3.org/2001/XMLSchema#string